Search

everythinglearnresearchcommunity

for

Search:↓

The patient has frontal fibrosing alopecia (FFA).

Oral isotretinoin effectively treats yellow facial papules in frontal fibrosing alopecia patients.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Recognizing skin symptoms helps diagnose and treat frontal fibrosing alopecia.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

FGF5 spliceosomes inhibit rabbit hair growth by affecting gene expression.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

More research is needed to better understand and treat Fibrosing Frontal Alopecia.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Aromatase gene variation may increase female hair loss risk.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

A mutation in the SREBF1 gene causes both hereditary mucoepithelial dysplasia and IFAP syndrome, which are related conditions.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.

Fetuin-A helps wounds heal without scars by promoting cell movement.

FLCN helps control iron levels in cells.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.